Research Article

The Burden and In-Hospital Mortality of Stroke Admissions at a Tertiary Level Hospital in Namibia: A Retrospective Cohort Study

Table 1

Demographics, characteristics, risk factors, and management of stroke patients.
(a)

Total ()Ischaemic stroke ()Haemorrhagic stroke () value

Age (years), <0.001
Male (, %)122 (55.5)68 (55.74)54 (44.3)0.079
Female (, %)98 (44.56)66 (67.4)32 (32.7)
Ethnicity
African ancestry (, %)164 (92.1)95 (57.9)69 (42.1)
Mixed ancestry (, %)8 (4.5)7 (87.5)1 (12.5)
Others (, %)6 (3.4)6 (100.0)0 (0.0)
Marital status
Single (, %)68 (53.9)42 (61.8)26 (38.2)
Married (, %)51 (40.5)32 (62.8)19 (37.3)
Divorced (, %)1 (0.8)0 (0.0)1 (100.0)
Widower (, %)6 (4.8)6 (100.0)0 (0.0)
Referral pattern
Khomas (, %)113 (52.1)71 (62.8)42 (37.2)
Other regions (, %)104 (47.9)63 (60.6)41 (39.4)
Vitals on admission
(i) Systolic BP (mmHg), median (IQR)149 (131-177)143 (128-158)169.5 (145-196)<0.001
(ii) Diastolic BP (mmHg), median (IQR)92 (80-104)87 (78-98.5)102 (88-118)<0.001
(iii) Temperature (°C), median (IQR)36.5 (36-36.9)36.5 (36-36.9)36.5 (35.9-36.9)0.700
(iv) Random blood sugar (mmol), median (IQR)6.4 (5.7-8)6.5 (5.7-8.7)6.4 (5.7-7.9)0.806
Altered mental status, yes (, %)48 (28.57)25 (52.08)23 (47.92)0.078
Intubated on admission, yes (, %)11 (6.51)1 (9.09)10 (90.91)<0.001
Length of hospital stay (days), median (IQR)10 (4-18)11 (6-18)9 (4-18)0.209
Duration of Symptoms before admission (days), median (IQR)1 (0-3)1 (0-3)0 (0-3)0.116

Abbreviations: BP: blood pressure; IQR-interquartile range (Q1-Q3); (%): number (proportion); : .
(b)

TotalIschaemic strokeHaemorrhagic stroke value

Stroke risk factors
Hypertension, yes (, %)179 (86.5)104 (58.1)75 (41.9)0.015
Diabetes mellitus, yes (, %)40 (20.2)29 (72.50)11 (27.5)0.130
Dyslipidaemia, yes (, %)103 (51.2)76 (73.79)27 (26.2)0.001
Other cardiovascular diseases, yes (, %)16 (8.3)14 (87.50)2 (12.5)0.007
Smoking history, yes (, %)51 (39.5)36 (70.59)15 (29.4)0.363
Alcohol history, yes (, %)79 (58.5)44 (55.70)35 (44.3)0.022
HIV-positive, yes (, %)28 (35.0)19 (67.86)9 (32.1)0.623
Previous stroke, yes (, %)14 (8.8)12 (85.71)2 (14.3)0.081
Medical and rehabilitation treatment
Thrombolysis, yes (, %)3 (2.2)3 (2.2)N/A
Intravenous labetalol/hydralazine, yes (, %)47 (25.9)7 (14.9)40 (85.1)<0.001
ASA/Clop, yes (, %)4 (3.2)4 (3.2)N/A
ASA/Clop + statin, yes (, %)82 (66.1)82 (66.1)N/A
DAPT + statin, yes (, %)29 (23.4)29 (23.4)N/A
Anticoagulation, yes (, %)9 (7.3)9 (7.3)N/A
1 antihypertensive agent, yes (, %)26 (14.5)16 (61.5)10 (38.5)
2 antihypertensive agents, yes (, %)45 (25.1)36 (80.0)9 (20.0)
3 or more antihypertensive agents, yes (, %)77 (43.0)35 (45.5)42 (54.6)
Physiotherapy, yes (, %)85 (51.8)58 (68.2)27 (31.8)0.184
Occupational therapy, yes (, %)19 (11.6)11 (57.9)8 (42.1)0.595
Speech therapy, yes (, %)5 (2.6)3 (60.0)2 (40.0)1.000
Outcome
Died, yes (, %)57 (26.4)27 (47.4)30 (52.6)0.013
Discharged, yes (, %)159 (73.6)105 (66.0)54 (33.9)0.013

Abbreviations: ASA: aspirin; Clop: clopidogrel; CVS: cardiovascular disease; DAPT: dual antiplatelet therapy; (%): number (proportion); NA: not applicable.